Document is current
Any future updates will be listed below
-
Authors
Foldvary-Schaefer, Nancy https://orcid.org/0000-0001-8900-3280
Maski, Kiran https://orcid.org/0000-0003-4073-4036
Schneider, Logan D. https://orcid.org/0000-0001-8729-5224
Dauvilliers, Yves https://orcid.org/0000-0003-0683-6506
-
Funding
Funding for this research was provided by:
Jazz Pharmaceuticals
- License Information
-
More Information
Article History
Received: 24 October 2025
Revised: 24 October 2025
Accepted: 4 November 2025
First Online: 20 December 2025
Declarations
:
: Not applicable.
: All authors have seen and approved the manuscript and consent to its publication.
: This review does not report new data from a clinical trial.
: All N/A.
: None.
: N Foldvary-Schaefer has received research grants from Avadel, Jazz Pharmaceuticals, Harmony, Suven, Takeda, and Vanda; served on a publication committee and advisory committees for Jazz Pharmaceuticals; and received royalties from UpToDate and Oxford University Press. K Maski has received personal compensation for serving on advisory boards for Alkermes, Avadel, Eisai, Harmony Biosciences, Jazz Pharmaceuticals, and Takeda. She receives research support from Harmony Biosciences, Jazz Pharmaceuticals, and Takeda. She receives research support from National Institutes of Health, National Institute of Neurological Disorders and Stroke under award number R61NS130215-01A1. LD Schneider has received personal compensation for serving on advisory boards and speakers bureaus for Avadel, Eisai, and Jazz Pharmaceuticals. Y Dauvilliers is a consultant for and has participated in advisory boards for Avadel, Bioprojet, Centessa, Harmony Biosciences, Idorsia, Jazz Pharmaceuticals, and Takeda.
